Zevra Therapeutics宣布,已根据纳斯达克上市规则5635(C)(4)的规定,向公司新任首席财务官授予了一项激励性股权。此项授予是作为其入职公司的激励方案的一部分,符合相关法规要求。
Zevra Therapeutics宣布,已根据纳斯达克上市规则5635(C)(4)的规定,向公司新任首席财务官授予了一项激励性股权。此项授予是作为其入职公司的激励方案的一部分,符合相关法规要求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.